Condition: Oral Squamous Cell Carcinoma · Oropharynx Squamous Cell Carcinoma · Premalignant Lesion · Sponsor: Viome
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
This description comes directly from the study's public registry record.
Mory Mehrtash, MSc · 425-300-6933 · studies@viome.com
Momchilo Vuyisich, PhD · 425-300-6933 · studies@viome.com
Always discuss trial participation with your own doctor first.
| NYMC | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05451303